Biohaven Ltd. Stock Prediction
AI-powered sentiment analysis and prediction trends for BHVN, updated each market day.
BHVN AI Sentiment
AI sees no strong directional signal for Biohaven Ltd. stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Sector
Exchange
Market Cap
$1,582,424,543
Cap Tier
Employees
274
Headquarters
NEW HAVEN, CT
Listed Since
Sept. 23, 2022
Website
BHVN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BHVN Volatility
Biohaven Ltd. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
